-
The FDA has approved the first nasally administered flu vaccine. This cold-adapted, temperature sensitive, attenuated, trivalent vaccine is manufactured by MedImmune Vaccine, Inc. and marketed by MedImmune and Wyeth under the name FluMist. The nasal flu vaccine should be available this fall.
-
The Women's Health Initiative (WHI) was halted 1 year ago, but fallout
from this landmark study continues. The study was designed to identify
the risks or benefits of estrogen plus progesterone vs placebo in
healthy postmenopausal women.
-
-
The Platelia Aspergillus EIA for detecting Aspergillus galactomannan in blood has been recently approved by the Food and Drug Administration for use in the United States.
-
Pyrazinamide was the most frequent cause of drug-related adverse events, especially hepatitis, among patients with tuberculosis receiving first-line drugs.
-
Kyasanur Forest disease, also known as monkey fever, is a cause of hemorrhagic fever with late CNS manifestations in a geographically delimited area of India.
-
Guangdong province in China, having brought SARS under control, is now facing its seasonal epidemic of Japanese encephalitis.
-
Ross River and Barmah viruses are causes of febrile illness often associated with severe joint symptoms, which may persist for months.
-
-
Neither adding a single dose of ceftriaxone to a 10-day course of doxycycline nor extending the duration of doxycycline therapy to 20 days is better than a straightforward 10-day course of oral doxycycline in the treatment of patients with erythema migrans.
